Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Tumor Blood Testing Market Size Analysis from 2022 to 2027

1.5.1 Global Tumor Blood Testing Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Tumor Blood Testing Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Tumor Blood Testing Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Tumor Blood Testing Industry Impact

Chapter 2 Global Tumor Blood Testing Competition by Types, Applications, and Top Regions and Countries

2.1 Global Tumor Blood Testing (Volume and Value) by Type

2.1.1 Global Tumor Blood Testing Consumption and Market Share by Type (2016-2021)

2.1.2 Global Tumor Blood Testing Revenue and Market Share by Type (2016-2021)

2.2 Global Tumor Blood Testing (Volume and Value) by Application

2.2.1 Global Tumor Blood Testing Consumption and Market Share by Application (2016-2021)

2.2.2 Global Tumor Blood Testing Revenue and Market Share by Application (2016-2021)

2.3 Global Tumor Blood Testing (Volume and Value) by Regions

2.3.1 Global Tumor Blood Testing Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Tumor Blood Testing Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Tumor Blood Testing Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Tumor Blood Testing Consumption by Regions (2016-2021)

4.2 North America Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

4.10 South America Tumor Blood Testing Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Tumor Blood Testing Market Analysis

5.1 North America Tumor Blood Testing Consumption and Value Analysis

5.1.1 North America Tumor Blood Testing Market Under COVID-19

5.2 North America Tumor Blood Testing Consumption Volume by Types

5.3 North America Tumor Blood Testing Consumption Structure by Application

5.4 North America Tumor Blood Testing Consumption by Top Countries

5.4.1 United States Tumor Blood Testing Consumption Volume from 2016 to 2021

5.4.2 Canada Tumor Blood Testing Consumption Volume from 2016 to 2021

5.4.3 Mexico Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 6 East Asia Tumor Blood Testing Market Analysis

6.1 East Asia Tumor Blood Testing Consumption and Value Analysis

6.1.1 East Asia Tumor Blood Testing Market Under COVID-19

6.2 East Asia Tumor Blood Testing Consumption Volume by Types

6.3 East Asia Tumor Blood Testing Consumption Structure by Application

6.4 East Asia Tumor Blood Testing Consumption by Top Countries

6.4.1 China Tumor Blood Testing Consumption Volume from 2016 to 2021

6.4.2 Japan Tumor Blood Testing Consumption Volume from 2016 to 2021

6.4.3 South Korea Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 7 Europe Tumor Blood Testing Market Analysis

7.1 Europe Tumor Blood Testing Consumption and Value Analysis

7.1.1 Europe Tumor Blood Testing Market Under COVID-19

7.2 Europe Tumor Blood Testing Consumption Volume by Types

7.3 Europe Tumor Blood Testing Consumption Structure by Application

7.4 Europe Tumor Blood Testing Consumption by Top Countries

7.4.1 Germany Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.2 UK Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.3 France Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.4 Italy Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.5 Russia Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.6 Spain Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.7 Netherlands Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.8 Switzerland Tumor Blood Testing Consumption Volume from 2016 to 2021

7.4.9 Poland Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 8 South Asia Tumor Blood Testing Market Analysis

8.1 South Asia Tumor Blood Testing Consumption and Value Analysis

8.1.1 South Asia Tumor Blood Testing Market Under COVID-19

8.2 South Asia Tumor Blood Testing Consumption Volume by Types

8.3 South Asia Tumor Blood Testing Consumption Structure by Application

8.4 South Asia Tumor Blood Testing Consumption by Top Countries

8.4.1 India Tumor Blood Testing Consumption Volume from 2016 to 2021

8.4.2 Pakistan Tumor Blood Testing Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Tumor Blood Testing Market Analysis

9.1 Southeast Asia Tumor Blood Testing Consumption and Value Analysis

9.1.1 Southeast Asia Tumor Blood Testing Market Under COVID-19

9.2 Southeast Asia Tumor Blood Testing Consumption Volume by Types

9.3 Southeast Asia Tumor Blood Testing Consumption Structure by Application

9.4 Southeast Asia Tumor Blood Testing Consumption by Top Countries

9.4.1 Indonesia Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.2 Thailand Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.3 Singapore Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.4 Malaysia Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.5 Philippines Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.6 Vietnam Tumor Blood Testing Consumption Volume from 2016 to 2021

9.4.7 Myanmar Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 10 Middle East Tumor Blood Testing Market Analysis

10.1 Middle East Tumor Blood Testing Consumption and Value Analysis

10.1.1 Middle East Tumor Blood Testing Market Under COVID-19

10.2 Middle East Tumor Blood Testing Consumption Volume by Types

10.3 Middle East Tumor Blood Testing Consumption Structure by Application

10.4 Middle East Tumor Blood Testing Consumption by Top Countries

10.4.1 Turkey Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.3 Iran Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.5 Israel Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.6 Iraq Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.7 Qatar Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.8 Kuwait Tumor Blood Testing Consumption Volume from 2016 to 2021

10.4.9 Oman Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 11 Africa Tumor Blood Testing Market Analysis

11.1 Africa Tumor Blood Testing Consumption and Value Analysis

11.1.1 Africa Tumor Blood Testing Market Under COVID-19

11.2 Africa Tumor Blood Testing Consumption Volume by Types

11.3 Africa Tumor Blood Testing Consumption Structure by Application

11.4 Africa Tumor Blood Testing Consumption by Top Countries

11.4.1 Nigeria Tumor Blood Testing Consumption Volume from 2016 to 2021

11.4.2 South Africa Tumor Blood Testing Consumption Volume from 2016 to 2021

11.4.3 Egypt Tumor Blood Testing Consumption Volume from 2016 to 2021

11.4.4 Algeria Tumor Blood Testing Consumption Volume from 2016 to 2021

11.4.5 Morocco Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 12 Oceania Tumor Blood Testing Market Analysis

12.1 Oceania Tumor Blood Testing Consumption and Value Analysis

12.2 Oceania Tumor Blood Testing Consumption Volume by Types

12.3 Oceania Tumor Blood Testing Consumption Structure by Application

12.4 Oceania Tumor Blood Testing Consumption by Top Countries

12.4.1 Australia Tumor Blood Testing Consumption Volume from 2016 to 2021

12.4.2 New Zealand Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 13 South America Tumor Blood Testing Market Analysis

13.1 South America Tumor Blood Testing Consumption and Value Analysis

13.1.1 South America Tumor Blood Testing Market Under COVID-19

13.2 South America Tumor Blood Testing Consumption Volume by Types

13.3 South America Tumor Blood Testing Consumption Structure by Application

13.4 South America Tumor Blood Testing Consumption Volume by Major Countries

13.4.1 Brazil Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.2 Argentina Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.3 Columbia Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.4 Chile Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.5 Venezuela Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.6 Peru Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Tumor Blood Testing Consumption Volume from 2016 to 2021

13.4.8 Ecuador Tumor Blood Testing Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Tumor Blood Testing Business

14.1 Guardant Health

14.1.1 Guardant Health Company Profile

14.1.2 Guardant Health Tumor Blood Testing Product Specification

14.1.3 Guardant Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Roche

14.2.1 Roche Company Profile

14.2.2 Roche Tumor Blood Testing Product Specification

14.2.3 Roche Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Trovagene

14.3.1 Trovagene Company Profile

14.3.2 Trovagene Tumor Blood Testing Product Specification

14.3.3 Trovagene Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Genomic Health

14.4.1 Genomic Health Company Profile

14.4.2 Genomic Health Tumor Blood Testing Product Specification

14.4.3 Genomic Health Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Pathway Genomics

14.5.1 Pathway Genomics Company Profile

14.5.2 Pathway Genomics Tumor Blood Testing Product Specification

14.5.3 Pathway Genomics Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Bio-Techne

14.6.1 Bio-Techne Company Profile

14.6.2 Bio-Techne Tumor Blood Testing Product Specification

14.6.3 Bio-Techne Tumor Blood Testing Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Tumor Blood Testing Market Forecast (2022-2027)

15.1 Global Tumor Blood Testing Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Tumor Blood Testing Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Tumor Blood Testing Value and Growth Rate Forecast (2022-2027)

15.2 Global Tumor Blood Testing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Tumor Blood Testing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Tumor Blood Testing Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Tumor Blood Testing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Tumor Blood Testing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Tumor Blood Testing Consumption Forecast by Type (2022-2027)

15.3.2 Global Tumor Blood Testing Revenue Forecast by Type (2022-2027)

15.3.3 Global Tumor Blood Testing Price Forecast by Type (2022-2027)

15.4 Global Tumor Blood Testing Consumption Volume Forecast by Application (2022-2027)

15.5 Tumor Blood Testing Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology